Back to search

Article

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis

2022-09-03

Abstract excerpt

<h4>ABSTRACT</h4> Sustained ANKRD26 expression associated with germline ANKRD26 mutations causes Thrombocytopenia 2 (THC2), an inherited platelet disorder associated with leukemia predisposition. Some of those patients present also erythrocytosis and/or leukocytosis. Using multiple human-relevant in vitro models (cell lines, primary patient cells and patient-derived iPSCs) we demonstrate for the first time that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
31d4e078-3cbb-50b4-98cc-fffd03b46231
DOI
10.1101/2022.09.01.506160
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesisDOI 10.1101/2022.09.01.506160
Select a neighboring publication to make it the new centre.